Skip to main content

Self-management and HeAlth Promotion in Early-stage dementia with e-learning for carers – A randomised controlled trial


Start Date
End Date
Total Funding
€ 2 887 000
Funding Programme
European Countries Involved
We will develop and validate an intervention (SHAPE) in 330 people with mild dementia; combining self-management, health promotion, and e-learning. The study is a multi-site, randomised, controlled, single-blinded trial with parallel groups. The intervention group is compared with treatment as usual (TAU). The primary outcome is to evaluate the effectiveness of the intervention in improving self-efficacy in people with dementia compared to treatment as usual (TAU). Secondary outcomes are to evaluate the effectiveness of the SHAPE intervention in (a) improving mood, well-being, quality of life and health outcomes in people with dementia compared to TAU; (b) decreasing carer stress, general distress, knowledge about dementia and perceived access to support services compared to TAU; (c) producing health behaviour changes based on self- and family report compared to TAU; d) reducing utilisation of health and social care and e) estimating the cost-effectiveness of the self-management compared to TAU (WP5). Our 36-month project is divided into eight work packages: Project management (WP1); Combining the interventions (WP2); Implementation Strategies (WP3); an RCT study (WP4) to measure health effects; a study of Economic effects (WP5); a Qualitative study (WP6) to understand and suggest improvement to the intervention; a Replication study (WP7) to prepare broader adoption; and Dissemination and Exploitation (WP8) to reach all stakeholders with targeted messages facilitating a broad reach and ensuring use of the intervention beyond the project.
Project partners
Stavanger University Hospital
Norwegian National Advisory Unit on Ageing and Health
University of Exeter
London School of Economics & Political Science
University of New South Wales
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).